
|
Number 10 -
OCTOBER 2005 ULCERATIVE COLITIS - MEDICAL TREATMENT Janke KH, Steder-Neukamm U, Bauer M, Raible A, Meisner C, Hoffmann JC, Gregor M, Klump B, Hauser W. Quality of Life Assessment in Inflammatory Bowel Disease (IBD): German Version of the Inflammatory Bowel Disease Questionnaire (IBDQ-D; Disease-Specific Instrument for Quality of Life Assessment) - First Application and Comparison with International Investigations. Gesundheitswesen. 2005 Aug-Sep;67(8-9):656-64. German. Lindberg J, Stenling R, Palmqvist R, Rutegard J. Efficiency of colorectal cancer surveillance in patients with ulcerative colitis: 26 years' experience in a patient cohort from a defined population area. Scand J Gastroenterol. 2005 Sep;40(9):1076-80.
Tsujikawa T, Andoh A,
Sakaki M, Ishizuka I, Araki Y, Koyama S, Fujiyama Y.
Operative indications for patients with refractory or severe
ulcerative colitis. Stange EF, Schmid M, Fellermann K, Wehkamp J. [Chronic inflammatory bowel diseases (IBD): novel pathophysiological concepts and their clinical relevance] Schweiz Rundsch Med Prax. 2005 Sep 14;94(37):1429-32.
Karimi O, Pena AS, van Bodegraven
AA.
Probiotics (VSL#3) in arthralgia in patients with ulcerative colitis
and Crohn's disease: A pilot study. Drugs Today
(Barc). 2005 Jul;41(7):453-9. Abdelrazeq AS, Wilson TR, Leitch DL, Lund JN, Leveson SH. Ileitis in Ulcerative Colitis: Is It a Backwash? Dis Colon Rectum. 2005 Aug 29;
Torok HP, Glas J, Hollay
HC, Gruber R, Osthoff M, Tonenchi L, Bruckl C, Mussack T, Folwaczny
M, Folwaczny C.
Serum Antibodies in First-Degree Relatives of Patients with IBD: A
Marker of Disease Susceptibility? A Follow-Up
Pilot-Study after 7 Years.
Ingram JR, Rhodes J,
Collins PW, Williams GT, Newcombe RG, Thomas GA.
Plasma fibrinogen in ulcerative colitis: The effect of disease
activity and nicotine therapy in a randomised controlled trial.
Silverberg MS, Satsangi J,
Ahmad T, Arnott ID, Bernstein CN, Brant SR, Caprilli R, Colombel JF,
Gasche C, Geboes K, Jewell DP, Karban A, Loftus Jr EV, Pena AS,
Riddell RH, Sachar DB, Schreiber S, Steinhart AH, Targan SR,
Vermeire S, Warren BF.
Toward an integrated clinical, molecular and serological
classification of inflammatory bowel disease: Report of a Working
Party of the 2005 Montreal World Congress of Gastroenterology. Ingram JR, Rhodes J, Evans BK, Newcombe RG, Thomas GA. Comparative study of enema retention and preference in ulcerative colitis. Postgrad Med J. 2005 Sep;81(959):594-8. Bernstein CN, Wajda A, Blanchard JF. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. Gastroenterology. 2005 Sep;129(3):827-36. Marohn MR, Hanly EJ, McKenna KJ, Varin CR. Laparoscopic Total Abdominal Colectomy in the Acute Setting. J Gastrointest Surg. 2005 September - October;9(7):881-887. Larson DW, Dozois E, Sandborn WJ, Cima R. Total laparoscopic proctocolectomy with Brooke ileostomy: a novel incisionless surgical treatment for patients with ulcerative colitis. Surg Endosc. 2005 Jul 28;
Brunner M, Vogelsang H,
Greinwald R, Kletter K, Kvaternik H, Schrolnberger C, Eichler HG,
Brunner H, Dudczak R, Muller M.
Colonic spread and serum pharmacokinetics of budesonide foam in
patients with mildly to moderately active ulcerative colitis. Park IJ, Yu CS, Kim HC, Jung YH, Han KR, Yang SK, Kim JC. Analysis of pouchitis after restorative proctocolectomy Korean J Gastroenterol. 2005 Aug;46(2):99-104.
Trickett JP, Tilney HS,
Gudgeon AM, Mellor SG, Edwards DP.
Management of the rectal stump after emergency sub-total colectomy:
which surgical option is associated with the lowest morbidity? Israeli E, Grotto I, Gilburd B, Balicer RD, Goldin E, Wiik A, Shoenfeld Y. Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease. Gut. 2005 Sep;54(9):1232-6.
Matsushita M, Takakuwa H,
Matsubayashi Y, Nishio A, Ikehara S, Okazaki K.
Appendix is a priming site in the development of ulcerative colitis. Mitomi H, Okayasu I, Bronner MP, Kanazawa H, Nishiyama Y, Otani Y, Sada M, Tanabe S, Igarashi M, Katsumata T, Saigenji K. Comparative histologic assessment of proctocolectomy specimens from Japanese and American patients with ulcerative colitis with or without dysplasia. Int J Surg Pathol. 2005 Jul;13(3):259-65.
Ockenga J, Borchert K,
Stuber E, Lochs H, Manns MP, Bischoff SC.
Glutamine-enriched total parenteral nutrition in patients with
inflammatory bowel disease.
van der Woude CJ, Moshage
H, Homan M, Kleibeuker JH, Jansen PL, van Dekken H.Expression
of apoptosis related proteins during malignant progression in
chronic ulcerative colitis. Targan SR, Karp LC. Defects in mucosal immunity leading to ulcerative colitis. Immunol Rev. 2005 Aug;206:296-305. Solem CA, Loftus EV Jr, Tremaine WJ, Harmsen WS, Zinsmeister AR, Sandborn WJ. Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease.Inflamm Bowel Dis. 2005 Aug;11(8):707-12. Zhong YQ, Huang HR, Zhu ZH, Chen QK, Zhan J, Xing LC. Effects of sulfasalazine on biopsy mucosal pathologies and histological grading of patients with active ulcerative colitis. World J Gastroenterol. 2005 Jul 28;11(28):4435-8.
Chambers WM, Warren BF,
Jewell DP, Mortensen NJ.
Cancer surveillance in ulcerative colitis. Bednarz W, Olewinski R, Wojczys R, Sutkowski K, Domoslawski P, Balcerzak W. Ileal-pouch-anal anastomosis after restorative proctocolectomy in patients with ulcerative colitis or familial adenomatous polyposis.Hepatogastroenterology. 2005 Jul-Aug;52(64):1101-5. Gosselink MP, West RL, Kuipers EJ, Hansen BE, Schouten WR. Integrity of the anal sphincters after pouch-anal anastomosis: evaluation with three-dimensional endoanal ultrasonography. Dis Colon Rectum. 2005 Sep;48(9):1728-35.
Arai K, Koganei K, Kimura H, Akatani M,
Kitoh F, Sugita A, Fukushima T.
Incidence and outcome of complications following restorative
proctocolectomy.
Marteau P, Probert CS,
Lindgren S, Gassul M, Tan TG, Dignass A, Befrits R, Midhagen G,
Rademaker J, Foldager M.
Combined oral and enema treatment with Pentasa (mesalazine) is
superior to oral therapy alone in patients with extensive
mild/moderate active ulcerative colitis: a randomised, double blind,
placebo controlled study. Gibson PR, Muir JG. Reinforcing the mucus: a new therapeutic approach for ulcerative colitis? Gut. 2005 Jul;54(7):900-3. Review. Gionchetti P, Lammers KM, Rizzello F, Campieri M. Probiotics and barrier function in colitis. Gut. 2005 Jul;54(7):898-900. Review. Abdelrazeq AS, Lund JN, Leveson SH. Implications of pouchitis on the functional results following stapled restorative proctocolectomy. Dis Colon Rectum. 2005 Sep;48(9):1700-7.
Ikeuchi H, Nakano H, Uchino M, Nakamura
M, Noda M, Yanagi H, Yamamura T.
Safety of one-stage restorative proctocolectomy for ulcerative
colitis. |